Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
The recall involves 174 units of Philips OR Tables with product codes 722023, 722035, and 722015. These devices were distributed worldwide, including the U.S. and 45 other countries. The tables are classified as Class II medical devices.
The affected systems may not perform as intended due to deterioration of internal components such as the CMOS battery and hard disk drive. If these components fail, motorized movements will be unavailable, posing a high hazard for users.
There are no reported injuries or deaths related to this recall. The issue may disrupt the functionality of the OR tables, affecting medical procedures.
Stop using the recalled OR tables immediately. Contact Philips Medical Systems or your healthcare provider for further instructions and follow the recall process.
For questions, contact Philips Medical Systems Nederland B.V. at their website or customer service hotline.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.